Posted inNews and Updates
AI Outperforms Physicians in Key Diagnostic Tasks
New research confirms AI now matches or exceeds physician performance in diagnostics. Discover how machine learning is redefining the future of patient care.
Posted inNews and Updates
Daily Probiotics May Significantly Reduce Anxiety and Depression
New research explores how daily probiotics influence the gut-brain axis to alleviate symptoms of depression and anxiety. Learn the science behind it.
Posted inNews and Updates
Adaptive DBS: How New Brain Tech Is Changing Clinical Trials
Adaptive Deep Brain Stimulation is forcing a rethink of CNS clinical trial design. Can new data models meet FDA requirements for this life-changing tech?
Posted inNews and Updates
Zabopegdutide Shows 81.8% MASH Fibrosis Response in Trial
Zabopegdutide shows 81.8% fibrosis response in Phase 2 MASH trials. Discover how this potential breakthrough treatment impacts liver health and prognosis.
Posted inNews and Updates
uniQure Targets BLA for AMT-130 Gene Therapy in Huntington’s
uniQure announces BLA submission plans for AMT-130, a breakthrough gene therapy targeting the root cause of Huntington’s disease. Learn the latest updates.
Posted inNews and Updates
Olorofim Shows Success in Phase 3 Invasive Aspergillosis Trial
Olorofim hits Phase 3 non-inferiority goals for treating Invasive Aspergillosis, offering a new hope for patients with drug-resistant fungal infections.
Posted inNews and Updates
FDA Reviews New Combo Therapy for Refractory B-Cell Lymphoma
The FDA is reviewing a new Lunsumio and Polivy combo for relapsed B-cell lymphoma. Discover how this dual-targeted therapy could transform patient outcomes.
Posted inNews and Updates
FDA Approves Utebzi: First Oral Carbapenem for UTIs
The FDA has approved Utebzi, the first oral carbapenem for complicated UTIs. Learn how this breakthrough antibiotic is transforming outpatient clinical care.
Posted inNews and Updates
New Human Trial Targets Aging Immune Cells to Boost Immunity
A landmark clinical trial is testing senolytic drugs to clear aging "zombie cells." Discover how this could revitalize the immune system and fight aging.
Posted inNews and Updates
Postbiotic Gummies May Reduce Gum Bleeding in Six Weeks
New clinical findings reveal that daily postbiotic gummies can reduce gum bleeding in just six weeks, offering a promising new tool for oral health care.